[Tuberculosis treatment for children: An update]

Area of Science:

• Public Health
• Infectious Diseases
• Pediatrics

Background:

• Tuberculosis (TB) is a leading global infectious disease with high morbidity and mortality.
• Pediatric TB is a neglected epidemic, complicated by diagnostic challenges and lower infectivity in children.
• Multidrug-resistant TB (MDR TB) is a growing concern in Europe, with Spain having a high incidence of pediatric cases.

Purpose of the Study:

• To address the challenges in pediatric TB management, especially drug-resistant cases.
• To provide updated national recommendations for the care of pediatric TB patients and contacts.
• To replace previous national guidelines with evidence-based strategies.

Main Methods:

• Review of international guidelines and recent scientific evidence.
• Consensus development by a national group of pediatric TB experts.
• Formulation of new recommendations for managing pediatric TB contacts, latent infection, and active disease.

Main Results:

• Paediatric TB is a public health priority in Spain, with over 4% prevalence of drug-resistant TB.
• Difficulties in diagnosis and lack of pediatric drug formulations are major control challenges.
• New recommendations cover management of contacts, latent infection, and active TB, with a focus on drug resistance.

Conclusions:

• Updated guidelines are crucial for managing pediatric TB, especially drug-resistant forms.
• Addressing diagnostic and therapeutic challenges is essential for controlling childhood TB.
• These recommendations aim to improve patient outcomes and public health in Spain.